Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

120 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Rhof promotes murine marginal zone B cell development.
Kishimoto M, Matsuda T, Yanase S, Katsumi A, Suzuki N, Ikejiri M, Takagi A, Ikawa M, Kojima T, Kunishima S, Kiyoi H, Naoe T, Matsushita T, Maruyama M. Kishimoto M, et al. Among authors: ikejiri m. Nagoya J Med Sci. 2014 Aug;76(3-4):293-305. Nagoya J Med Sci. 2014. PMID: 25741038 Free PMC article.
Targeted disruption of mouse ortholog of the human MYH9 responsible for macrothrombocytopenia with different organ involvement: hematological, nephrological, and otological studies of heterozygous KO mice.
Matsushita T, Hayashi H, Kunishima S, Hayashi M, Ikejiri M, Takeshita K, Yuzawa Y, Adachi T, Hirashima K, Sone M, Yamamoto K, Takagi A, Katsumi A, Kawai K, Nezu T, Takahashi M, Nakashima T, Naoe T, Kojima T, Saito H. Matsushita T, et al. Among authors: ikejiri m. Biochem Biophys Res Commun. 2004 Dec 24;325(4):1163-71. doi: 10.1016/j.bbrc.2004.10.147. Biochem Biophys Res Commun. 2004. PMID: 15555549
Establishment of mouse model of MYH9 disorders: heterozygous R702C mutation provokes macrothrombocytopenia with leukocyte inclusion bodies, renal glomerulosclerosis and hearing disability.
Suzuki N, Kunishima S, Ikejiri M, Maruyama S, Sone M, Takagi A, Ikawa M, Okabe M, Kojima T, Saito H, Naoe T, Matsushita T. Suzuki N, et al. Among authors: ikejiri m. PLoS One. 2013 Aug 20;8(8):e71187. doi: 10.1371/journal.pone.0071187. eCollection 2013. PLoS One. 2013. PMID: 23976996 Free PMC article.
Development of cutaneous squamous cell carcinoma during pembrolizumab therapy.
Mizutani K, Nakanishi T, Ikejiri M, Yuasa H, Matsushima Y, Kondo M, Nakai Y, Habe K, Nakatani K, Yamanaka K. Mizutani K, et al. Among authors: ikejiri m. J Dermatol. 2021 Jan;48(1):e7-e8. doi: 10.1111/1346-8138.15614. Epub 2020 Sep 17. J Dermatol. 2021. PMID: 32940367 No abstract available.
Plasma ADAMTS13, von Willebrand Factor (VWF), and VWF Propeptide Profiles in Patients With Connective Tissue Diseases and Antiphospholipid Syndrome.
Habe K, Wada H, Matsumoto T, Ohishi K, Ikejiri M, Tsuda K, Kondo M, Kamimoto Y, Ikeda T, Katayama N, Mizutani H. Habe K, et al. Among authors: ikejiri m. Clin Appl Thromb Hemost. 2017 Sep;23(6):622-630. doi: 10.1177/1076029615625832. Epub 2016 Jan 11. Clin Appl Thromb Hemost. 2017. PMID: 26759371 Free article.
The effectiveness of measuring for fragmented red cells using an automated hematology analyzer in patients with thrombotic microangiopathy.
Abe Y, Wada H, Yamada E, Noda M, Ikejiri M, Nishioka J, Kobayashi T, Matsumoto T, Masuya M, Isaji S, Usui M, Uemoto S, Katayama N, Nobori T. Abe Y, et al. Among authors: ikejiri m. Clin Appl Thromb Hemost. 2009 May-Jun;15(3):257-62. doi: 10.1177/1076029608319879. Epub 2008 Jul 3. Clin Appl Thromb Hemost. 2009. PMID: 18603539 Free article.
120 results